CClinicalTrials.gg
Sign In
Status unknownNCT01751542Updated Dec 18, 2012

Mindfulness and Acceptance Group Therapy for Substance Use

A Phase 2 interventional study of Mindfulness + Residential Treatment and Residential treatment alone in Substance Use Disorder, sponsored by The University of Tennessee, Knoxville. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-12-18.

Sponsored by The University of Tennessee, Knoxville · Phase 2, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2012), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 2
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Randomized clinical trial comparing standard residential substance abuse treatment to standard residential treatment plus Mindfulness and Acceptance Group Therapy for substance use.

02

Conditions studied

  • Substance Use Disorder
03

In context

Substance-Related Disorders

2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.

This study's planned enrollment of 150 is above the median of 108 across 1,727 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

The University of Tennessee, Knoxville is the lead sponsor of 95 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • participating in inpatient substance use treatment at treatment facility

Exclusion criteria

Exclusion Criteria:

  • psychosis and mental impairment
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Mindfulness + residential treatment

    Mindfulness and Acceptance Group Therapy + residential treatment

    Behavioral: Mindfulness + Residential Treatment

  • Active comparator
    Residential Treatment

    Residential treatment alone

    Behavioral: Residential treatment alone

Interventions

  • BehavioralMindfulness + Residential Treatment
  • BehavioralResidential treatment alone
06

What researchers measure

Primary outcomes

  1. Substance use after discharge from treatment

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • University of Tenneessee & Cornerstone of Recovery
    Knoxville, Tennessee 37996, United States
    • Gregory Stuart, PhD · Contact · 865-974-3358
    • Gregory L Stuart, PhD · Principal investigator
    • Ryan Shorey, MA · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 18, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01751542
Lead sponsor
The University of Tennessee, Knoxville
Responsible party
Sponsor
First posted
Dec 18, 2012
Start date
Aug 2012
Primary completion
Dec 2013 (estimated)
Completion
Dec 2013 (estimated)
Last update
Dec 18, 2012

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Substance-Related Disorders→

Other studies from this sponsor

The University of Tennessee, Knoxville

Start the discussion